New mRNA boosters show promise in phase 2 trial
NCT ID NCT05960097
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study tested new COVID-19 mRNA booster vaccines in 692 healthy adults who had already received their primary vaccine series. The goal was to see how well the boosters boosted immunity and whether they were safe. Participants received either an experimental vaccine or a control vaccine, and researchers monitored side effects and antibody levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID - 19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Sacramento, California, 95864, United States
-
GSK Investigational Site
Hollywood, Florida, 33024, United States
-
GSK Investigational Site
Peoria, Illinois, 61614-4896, United States
-
GSK Investigational Site
Bruce, Australian Capital Territory, 2617, Australia
-
GSK Investigational Site
Blacktown, New South Wales, 2148, Australia
-
GSK Investigational Site
Botany, New South Wales, 2019, Australia
-
GSK Investigational Site
Brookvale, New South Wales, 2100, Australia
-
GSK Investigational Site
Coffs Harbour, New South Wales, 2450, Australia
-
GSK Investigational Site
Darlinghurst, New South Wales, 2010, Australia
-
GSK Investigational Site
Kanwal, New South Wales, 2259, Australia
-
GSK Investigational Site
Maroubra, New South Wales, 2035, Australia
-
GSK Investigational Site
Merewether, New South Wales, 2291, Australia
-
GSK Investigational Site
Blacktown, Queensland, 4006, Australia
-
GSK Investigational Site
Sherwood, Queensland, 4068, Australia
-
GSK Investigational Site
Tarragindi, Queensland, 4075, Australia
-
GSK Investigational Site
Adelaide, South Australia, 5000, Australia
-
GSK Investigational Site
Camberwell, Victoria, 3124, Australia
Conditions
Explore the condition pages connected to this study.